Compare JNJ & AVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | AVGO |
|---|---|---|
| Founded | 1886 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 2.0T |
| IPO Year | 2003 | 2018 |
| Metric | JNJ | AVGO |
|---|---|---|
| Price | $236.84 | $382.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 30 |
| Target Price | $238.20 | ★ $443.14 |
| AVG Volume (30 Days) | 6.2M | ★ 20.7M |
| Earning Date | 04-14-2026 | 06-04-2026 |
| Dividend Yield | ★ 2.36% | 0.64% |
| EPS Growth | 90.50 | ★ 287.80 |
| EPS | ★ 2.14 | 1.50 |
| Revenue | N/A | ★ $20,848,000,000.00 |
| Revenue This Year | $6.63 | $67.53 |
| Revenue Next Year | $7.43 | $53.74 |
| P/E Ratio | ★ $108.58 | $264.39 |
| Revenue Growth | N/A | ★ 18.21 |
| 52 Week Low | $149.04 | $244.18 |
| 52 Week High | $251.71 | $495.00 |
| Indicator | JNJ | AVGO |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 40.01 |
| Support Level | $233.83 | $314.01 |
| Resistance Level | $246.40 | $401.24 |
| Average True Range (ATR) | 4.17 | 18.87 |
| MACD | 0.99 | -7.70 |
| Stochastic Oscillator | 98.12 | 9.66 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.